PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (OTCQB: PHRRF) (CSE: PHRM), a specialty pharmaceutical company, today announced that the Company requested a post-complete letter clarification ...
(Reuters) - Thrive Capital is in talks to acquire about $1 billion stake in analytics software maker Databricks in a deal that would value the startup at about $55 billion, Bloomberg news reported on ...